235 related articles for article (PubMed ID: 9072852)
21. Foetal and neonatal thyroid disorders.
Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
[TBL] [Abstract][Full Text] [Related]
22. Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease.
Kashiwai T; Tada H; Asahi K; Hidaka Y; Tamaki H; Iwatani Y; Amino N
Endocr J; 1995 Jun; 42(3):405-12. PubMed ID: 7670570
[TBL] [Abstract][Full Text] [Related]
23. No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves' disease.
Amino N; Izumi Y; Hidaka Y; Takeoka K; Nakata Y; Tatsumi KI; Nagata A; Takano T
J Clin Endocrinol Metab; 2003 Dec; 88(12):5871-4. PubMed ID: 14671183
[TBL] [Abstract][Full Text] [Related]
24. Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity.
Zakarija M
J Clin Lab Immunol; 1983 Feb; 10(2):77-85. PubMed ID: 6133001
[TBL] [Abstract][Full Text] [Related]
25. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
[TBL] [Abstract][Full Text] [Related]
26. [The relationship between intrathyroidal dendritic cells and humoral immune disorder in Graves' disease].
Zhang HJ; Li DM; Gao DL; Zhang L; Cao J; Zhao ZH; Zhang YH; Xu L
Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):122-4. PubMed ID: 15840225
[TBL] [Abstract][Full Text] [Related]
27. [Neonatal hyperthyroidism in a premature infant born to a mother with Grave's disease].
Nicaise C; Gire C; Brémond V; Minodier P; Soula F; d'Ercole C; Palix C
Arch Pediatr; 2000 May; 7(5):505-8. PubMed ID: 10855389
[TBL] [Abstract][Full Text] [Related]
28. Thyroid carcinoma in Graves' disease.
Farbota LM; Calandra DB; Lawrence AM; Paloyan E
Surgery; 1985 Dec; 98(6):1148-53. PubMed ID: 2866590
[TBL] [Abstract][Full Text] [Related]
29. Serum cytokines levels in Graves' disease.
Al-Humaidi MA
Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
[TBL] [Abstract][Full Text] [Related]
30. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
[TBL] [Abstract][Full Text] [Related]
31. Thyrotoxicosis.
Kannan CR; Seshadri KG
Dis Mon; 1997 Sep; 43(9):601-77. PubMed ID: 9301645
[TBL] [Abstract][Full Text] [Related]
32. Onset of Graves' thyrotoxicosis after an attack of allergic rhinitis.
Hidaka Y; Masai T; Sumizaki H; Takeoka K; Tada H; Amino N
Thyroid; 1996 Aug; 6(4):349-51. PubMed ID: 8875759
[TBL] [Abstract][Full Text] [Related]
33. Thyroid-stimulating antibody (TSAb) of Graves' disease.
Zakarija M; McKenzie JM
Life Sci; 1983 Jan 3-10; 32(1-2):31-44. PubMed ID: 6131365
[TBL] [Abstract][Full Text] [Related]
34. Thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two patients with graves' disease-induced thyrotoxicosis.
Kinoshita H; Yasuda M; Kaneko S; Usui R; Inoshita S; Furumoto Y; Maruyama Y; Susa K; Suenaga M; Fujita H; Tomiyama J; Yakushiji F
Endocr Res; 2010; 35(4):183-7. PubMed ID: 20868289
[TBL] [Abstract][Full Text] [Related]
35. [Antibodies against the TSH receptor (TSAb) in Graves' disease and other thyroid diseases].
Gómez Sáez JM; Navarro Moreno MA; Soler Ramón J; Bonnin Lafuente R
Med Clin (Barc); 1982 Dec 1-31; 79(10):437-40. PubMed ID: 6130193
[No Abstract] [Full Text] [Related]
36. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report.
Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC
Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424
[TBL] [Abstract][Full Text] [Related]
37. Detection of thyroid-stimulating antibody in patients with inflammatory thyrotoxicosis.
Mitani Y; Shigemasa C; Kouchi T; Taniguchi S; Ueta Y; Yoshida A; Mashiba H
Horm Res; 1992; 37(4-5):196-201. PubMed ID: 1362712
[TBL] [Abstract][Full Text] [Related]
38. Neonatal thyrotoxicosis and conjugated hyperbilirubinemia.
Beroukhim RS; Moon TD; Felner EI
J Matern Fetal Neonatal Med; 2003 Jun; 13(6):426-8. PubMed ID: 12962270
[TBL] [Abstract][Full Text] [Related]
39. Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review.
van Dijk MM; Smits IH; Fliers E; Bisschop PH
Thyroid; 2018 Feb; 28(2):257-264. PubMed ID: 29325496
[TBL] [Abstract][Full Text] [Related]
40. Graves' disease and vertebral fracture: Possible pathogenic link in postmenopausal women.
Takedani K; Notsu M; Yamauchi M; Nawata K; Sugimoto T; Kanasaki K
Clin Endocrinol (Oxf); 2020 Aug; 93(2):204-211. PubMed ID: 32324288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
